Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Brooklyn Immunotherapeutics Inc (BTX)

Brooklyn Immunotherapeutics Inc (BTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,059
  • Shares Outstanding, K 58,826
  • Annual Sales, $ 0 K
  • Annual Income, $ -122,310 K
  • 60-Month Beta 4.61
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.80
Trade BTX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.33
  • Most Recent Earnings $-0.17 on 07/01/22
  • Latest Earnings Date 11/08/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.11
  • Growth Rate Est. (year over year) +908,281.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1699 +20.72%
on 10/13/22
0.3863 -46.91%
on 09/15/22
-0.1547 (-43.00%)
since 09/14/22
3-Month
0.1699 +20.72%
on 10/13/22
0.6400 -67.95%
on 07/18/22
-0.3967 (-65.92%)
since 07/14/22
52-Week
0.1699 +20.72%
on 10/13/22
10.1000 -97.97%
on 10/21/21
-8.9149 (-97.75%)
since 10/14/21

Most Recent Stories

More News
Brooklyn ImmunoTherapeutics Announces Results of Phase 2 Study of IRX-2 in Head and Neck Cancer

SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn” or the “Company”) today announces results from...

BTX : 4.1020 (+0.05%)
Brooklyn ImmunoTherapeutics Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

SAN DIEGO, June 17, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company...

BTX : 4.1020 (+0.05%)
Brooklyn ImmunoTherapeutics Announces Board Changes

SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company...

BTX : 4.1020 (+0.05%)
Brooklyn ImmunoTherapeutics Announces Changes to Executive Management: Matt Angel, Ph.D. Appointed Interim Chief Executive Officer and President, Andrew Jackson Appointed Chief Financial Officer Postpones 2022 Annual Meeting

SAN DIEGO, May 31, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company...

BTX : 4.1020 (+0.05%)
Brooklyn ImmunoTherapeutics Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Quarterly Report on Form 10-Q

SAN DIEGO, May 27, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring...

BTX : 4.1020 (+0.05%)
Brooklyn ImmunoTherapeutics Announces Establishment of New Research and Development Facility for Advancement of Engineered Cellular Medicines

Company has expanded team with scientific hires who hold research expertise in stem cells, synthetic RNA, nanoparticle delivery systems and immunology...

BTX : 4.1020 (+0.05%)
Brooklyn ImmunoTherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results

SAN DIEGO, April 15, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company focused on...

BTX : 4.1020 (+0.05%)
Noteworthy Monday Option Activity: BTX, GE, GRWG

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Brooklyn ImmunoTherapeutics Inc , where a total volume of 1,785 contracts has been...

BTX : 4.1020 (+0.05%)
Brooklyn ImmunoTherapeutics Announces Closing of $12 Million Private Placement

NEW YORK, March 09, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on...

BTX : 4.1020 (+0.05%)
Brooklyn ImmunoTherapeutics Welcomes Erin S. Enright and Heather B. Redman to Its Board of Directors

NEW YORK, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on...

BTX : 4.1020 (+0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Brooklyn ImmunoTherapeutics LLC. is a late clinical-stage biopharmaceutical company. It is focused on IL-2 cytokine-based therapies in treating patients with cancer. Brooklyn ImmunoTherapeutics LLC., formerly known as NTN Buzztime, is based in CARLSBAD, Calif.

See More

Key Turning Points

3rd Resistance Point 0.2454
2nd Resistance Point 0.2277
1st Resistance Point 0.2164
Last Price 4.1020
1st Support Level 0.1874
2nd Support Level 0.1697
3rd Support Level 0.1584

See More

52-Week High 10.1000
Fibonacci 61.8% 6.3067
Fibonacci 50% 5.1350
Last Price 4.1020
Fibonacci 38.2% 3.9632
52-Week Low 0.1699

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar